To evaluate the in situ distribution of different Mφ subpopulations, we used immunostaining to detect CD68+ Mφs, CD204+ Mφs, and CD169+ Mφs in the non-tumor (NT) and intra-tumor (IT) areas of HCC and GC. The gene discussed is MSR1; the disease is hepatocellular carcinoma.